Literature DB >> 19807545

Half standard deviation estimate of the minimally important difference in HRQOL scores?

Sepideh S Farivar1, Honghu Liu, Ron D Hays.   

Abstract

In addition to statistical significance, it is important to evaluate the magnitude of differences in health-related quality of life over time. Interest in establishing the minimal difference that is clinically important or the minimally important difference has burgeoned over the last few years. This review summarizes some of the leading approaches to estimating the minimally important difference, offers caveats on the minimally important difference estimation based on existing literature and provides recommendations for future work. The authors recommend using multiple anchors to estimate the minimally important difference, using only anchors that correspond to minimal change in health-related quality of life, reporting information about the variation around the estimates, and providing bounded estimates to reflect the uncertainty.

Year:  2004        PMID: 19807545     DOI: 10.1586/14737167.4.5.515

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  62 in total

Review 1.  Best (but oft-forgotten) practices: expressing and interpreting associations and effect sizes in clinical outcome assessments.

Authors:  Lori D McLeod; Joseph C Cappelleri; Ron D Hays
Journal:  Am J Clin Nutr       Date:  2016-02-10       Impact factor: 7.045

2.  Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

Authors:  J T Langfitt; B G Vickrey; M P McDermott; S Messing; A T Berg; S S Spencer; M R Sperling; C W Bazil; S Shinnar
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

3.  Cognitive profiles and heritability estimates in the Old Order Amish.

Authors:  Ryan M Kuehner; Peter Kochunov; Katie L Nugent; Deanna E Jurius; Anya Savransky; Christopher Gaudiot; Heather A Bruce; James Gold; Alan R Shuldiner; Braxton D Mitchell; L Elliot Hong
Journal:  Psychiatr Genet       Date:  2016-08       Impact factor: 2.458

4.  Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.

Authors:  Kim M Nielsen; Ann-Dorthe Zwisler; Rod S Taylor; Jesper H Svendsen; Jane Lindschou; Lindsey Anderson; Janus C Jakobsen; Selina K Berg
Journal:  Cochrane Database Syst Rev       Date:  2019-02-12

5.  Association of self-reported cognitive concerns with mobility in people with lower limb loss.

Authors:  Valerie E Kelly; Sara J Morgan; Dagmar Amtmann; Rana Salem; Brian J Hafner
Journal:  Disabil Rehabil       Date:  2016-10-19       Impact factor: 3.033

6.  Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL).

Authors:  Louis S Matza; Joseph A Johnston; Douglas E Faries; Karen G Malley; Meryl Brod
Journal:  Qual Life Res       Date:  2007-09-12       Impact factor: 4.147

7.  Health-related profiles of people with lower limb loss.

Authors:  Dagmar Amtmann; Sara J Morgan; Jiseon Kim; Brian J Hafner
Journal:  Arch Phys Med Rehabil       Date:  2015-04-25       Impact factor: 3.966

8.  Quality-of-life loss of people admitted to burn centers, United States.

Authors:  Ted Miller; Soma Bhattacharya; William Zamula; Dennis Lezotte; Karen Kowalske; David Herndon; James Fauerbach; Loren Engrav
Journal:  Qual Life Res       Date:  2012-12-08       Impact factor: 4.147

9.  Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.

Authors:  Helen M Pettinati; David R Gastfriend; Qunming Dong; Henry R Kranzler; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2008-11-25       Impact factor: 3.455

10.  Quality of Life Among Parents of Adolescent and Young Adult Brain Tumor Survivors.

Authors:  David K Buchbinder; Michelle A Fortier; Kathryn Osann; Justin Wilford; Violet Shen; Lilibeth Torno; Leonard S Sender; Susan K Parsons; Lari Wenzel
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.